Home / Companies / Results / Cipla posts net profit of Rs 665 cr in Q2, income from ops grows 15%

Cipla posts net profit of Rs 665 cr in Q2, income from ops grows 15%

The company's prescription biz grew 14% YoY supported by continued traction in the Covid portfolio

Premium

Cipla's trade generics business too, did well along with the consumer health division, driving the overall growth in the domestic market.

Sohini Das Mumbai

2 min read Last Updated : Nov 06 2020 | 10:42 PM IST

Mumbai-headquartered Cipla posted a 41 per cent rise in profit after tax for the September quarter riding on strong growth in the Indian market. Income from operations during the quarter grew 15 per cent to Rs 5,038 crore.

Cipla posted a net profit of Rs 665 crore. Earnings before income tax, depreciation and amortisation (Ebitda) came in at Rs 1,177 crore, up 29 per cent year on year (YoY).

The company's India business grew 17 per cent YoY as the prescription as well as the trade generics business did well. The prescription business grew 14 per cent YoY supported by

Topics : Cipla Q2 results Pharma industry drug market drug manufacturers South Africa US market USFDA

What you get on BS Premium?

Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
Pick your 5 favourite companies, get a daily email with all news updates on them.
Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
Preferential invites to Business Standard events.
Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.

VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in